Cargando…
Baricitinib/ceftriaxone/metoclopramide: Extrapyramidal syndrome and off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569084/ http://dx.doi.org/10.1007/s40278-021-04919-4 |
Ejemplares similares
-
Isolated Lingual Dystonia as the Manifestation of Acute Extrapyramidal Syndrome Induced by Metoclopramide
por: Verma, Rajesh, et al.
Publicado: (2019) -
Caspofungin/ceftriaxone/hydroxychloroquine: Brugada syndrome and off-label use: case report
Publicado: (2021) -
Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021) -
Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata, Ryohei, et al.
Publicado: (2016) -
Baricitinib/propofol: Pancreatitis following off-label use: case report
Publicado: (2022)